Shawn Cross - 03 Jun 2024 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Director
Signature
/s/ Shawn Cross
Issuer symbol
CYTH
Transactions as of
03 Jun 2024
Transactions value $
$0
Form type
4
Filing time
05 Jun 2024, 17:09:05 UTC
Previous filing
28 Dec 2023
Next filing
20 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Award $0 +8.89K +12.24% $0.00 81.5K 03 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Stock Option (Right to Buy) Award $0 +15.6K $0.00 15.6K 03 Jun 2024 Common Stock 15.6K $1.28 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the first quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $1.28 per share of common stock on June 3, 2024.
F2 The option vests over a one year period in equal quarterly installments.